Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to determine the efficacy and safety of 0.5% and 2% PRO 2000/5
gels compared to placebo in preventing vaginally acquired HIV infection.
Phase:
Phase 3
Details
Lead Sponsor:
Endo Pharmaceuticals
Collaborators:
Department for International Development, United Kingdom Medical Research Council